Wang Jennifer, Grignol Valerie P, Gronchi Alessandro, Luo Cheng-Hua, Pollock Raphael E, Tseng William W
Department of Surgery, Section of Surgical Oncology, University of Southern California, Keck School of Medicine, Los Angeles, CA, USA.
Division of Surgical Oncology, Ohio State University, The James Comprehensive Cancer Center, Columbus, OH, USA.
Chin Clin Oncol. 2018 Aug;7(4):39. doi: 10.21037/cco.2018.07.05.
Retroperitoneal sarcomas (RPS) are rare cancers that often reach massive size before detection. The mainstay of treatment for RPS is surgical resection, and complete resection is the only chance for potential cure. The management of RPS can be challenging and in individual cases, radiation and systemic therapy may be beneficial in both primary and recurrent disease. Further research through multi-institutional collaboration, ideally on a global level, is needed to better understand RPS and optimize management of this disease.
腹膜后肉瘤（RPS）是一种罕见的癌症，常在被发现之前就已长得很大。RPS的主要治疗方法是手术切除，完整切除是实现潜在治愈的唯一机会。RPS的治疗可能具有挑战性，在个别情况下，放疗和全身治疗对原发性和复发性疾病可能都有益处。需要通过多机构合作进行进一步研究，最好是在全球范围内，以更好地了解RPS并优化这种疾病的管理。
